Estimation and correlation of IC50 for the inhibition of human erythrocyte acetylcholinesterase by cis-diamminediaquaplatinum (II)

Anticancer Research

Volumn 17, Issue 6 D, 1997, Pages 4483-4486

  Kamal, Mohammad A ^a   Bakkar, Mohammad S ^a   Al Jafari, Abdulaziz A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Acetylcholinesterase; Cis diamminediaquaplatinum II; Erythrocyte; Fifty percent inhibition

Indexed keywords

ACETYLCHOLINESTERASE; CIS DIAMMINEDIAQUA PLATINUM II; CISPLATIN; CISPLATIN DERIVATIVE; UNCLASSIFIED DRUG; CHOLINESTERASE INHIBITOR;

ARTICLE; CONTROLLED STUDY; DOSE CALCULATION; DRUG CHOICE; DRUG POTENCY; ENZYME INHIBITION; ERYTHROCYTE; HUMAN; HUMAN CELL; MALE; MEDICAL DECISION MAKING; NORMAL HUMAN; PRIORITY JOURNAL; TIME; BLOOD; ENZYMOLOGY; ERYTHROCYTE MEMBRANE; KINETICS;

ACETYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; ERYTHROCYTE MEMBRANE; HUMANS; KINETICS; TIME FACTORS;

EID: 0031283136     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Teatini G, Meloni F, Bisail M, Milia V, Sanna G, Sarobba MG, Massidda B, Scotto T, Farris A: Neoadjuvant chemotherapy with cisplatinum and 5-fluorouracil in advanced head and neck cancer. J Chemother 2: 394-396, 1990.
2. Von Hoff DD, Schilsky R, Reichert CM, Reddick RL, Rozencweig M, Young RC, Muggia FM: Toxic effects of cis-dichlorodiammineplatinum (II) in man. Cancer Treat Rep 63: 1527-1531, 1979.
3. + binding to fumarase. Drug Metabol Drug Interact 12: 105-115, 1995.
4. Kodera Y, Akiyama S, Isobe K, Kondo K, Ito K, Yamauchi M, Takagi H: Expression of piglutathione S-transferase gene (GSTP1) in gastric cancer: lack of correlation with resistance against cis-diammine-dichloroplatinum (II). Eur J Cancer 30: 2158-2162, 1994.
5. Sadzuka Y, Shoji T, Takino Y: Effect of cisplatin on the activities of enzymes which protect against lipid peroxidation. Biochemical Pharmacol 43: 1872-1875, 1992.
6. Bernges F, Holler E: Ring-substituted diaqua(1, 2-diphenylethylenediamine) platinum(II) sulfate reacts with DNA through a dissociable complex. Eur J Biochem 208: 573-579, 1992.
7. Sorensen K, Gentinetta R, Brodback U: An amphiphile dependent form of human brain caudate nucleus acetylcholinesterase: Purification and properties. J Neurochem 39: 1050-1060, 1982.
8. Al-Jafari AA: Mercuric chloride effects on the kinetic parameters of human erythrocyte membrane-bound acetylcholinesterase. Biochem Mol Biol Int 36: 1243-1253, 1995.
9. Al-Jafari AA, Kamal MA, Duhaiman AS: The mode of inhibition of human erythrocyte membrane-bound acetylcholinesterase by cisplatin in vitro. J Enz Inhibit 8: 281-289, 1995.
10. Al-Jafari AA: Kinetics for the inhibition of acetylcholinesterase from human erythrocyte by cisplatin. Int J Biochem Cell Biol. 27: 965-970, 1995.
11. Kamal MA, Nasim FH and Al-Jafari AA: Investigation of the effect of anti-neoplastic drugs, cyclophosphamide, cisplatin and methotrexate on the turnover kinetics of human erythrocyte acetylcholinesterase. Biochem Mol Biol Int 39: 293-302, 1996.
12. 50 with time for the inhibition of human erythrocyte acetylcholinesterase by cisplatin. Cell Pharm 3: 45-48, 1996.
13. Kamal MA: Characterization of human erythrocyte membrane-bound acetylcholinesterase inhibition by cisplatin at reversible phase. Anticancer Res 16: 3725-3730, 1996.
14. Schaller W, Reisner H, Holler E: Kinetic investigation of the DNA platination reaction: evidence for a transient adduct between deoxyribonucleic acid and cis-platinum (II). Biochemistry 26: 943-950, 1987.
15. Kamal MA, Al-Jafari AA: The preparation and kinetic analysis of multiple forms of human erythrocyte acetylcholinesterase. Prep Biochem Biotech 26: 105-119, 1996.
16. Ellman GL, Courtney D, Andres V, Featherston RM: A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88-95, 1961.
17. Al-Jafari AA, Kamal MA: Optimization and kinetic studies of human erythrocyte membrane-bound acetylcholinesterase. Biochem Mol Biol Int 38: 577-586, 1996.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1953.
19. Al-Jafari AA, Kamal MA: The preparation and kinetic properties of multiple forms of chicken brain acetylcholinesterase. Cell Biochem Funct 12: 29-35, 1994.
20. Leatherbarrow RJ: GraFit Version, 3.0: Erithacus Software Ltd: Staines, U.K, 1992
21. Hodge AS, Humphrey DR, Rosenberry TL: Ambenonium is a rapidly reversible noncovalent inhibitor of acetylcholinesterase with one of the highest known affinities. Mol Pharmacol 41: 937-942, 1992.